misonidazole was covalently conjugated ( 3-68 mol drug/mol antibody ) to 19-9 monoclonal antibody directed against a colorectal carcinoma tumor-associated antigen as a method for targeting radiosensitizing agents .
C0003241
antibody
C0003250
monoclonal antibody